Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice Cream [NA]
A clinical trial evaluating two specialized ice cream formulations (brazzein-based with various sweeteners) for dietary therapy in nonalcoho…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: An Imaging-based Quantitative Biomarker Assay for NAFLD in Children [NA]
This clinical trial update describes an imaging-based quantitative biomarker assay being studied for pediatric nonalcoholic fatty liver dise…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Recruitment is ongoing for a study examining screening and follow-up in patients with HIV infection and metabolic-associated fatty liver dis…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis [Phase 3]
A Phase 3 clinical trial evaluating hydroxychloroquine for nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Non-Invasive Quantification of Liver Health in NASH (N-QUAN) [NA]
The N-QUAN trial, evaluating non-invasive quantification of liver health in nonalcoholic steatohepatitis (NASH), is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Comparison of ALD, NASH, and Healthy Control Patients
The Cleveland Clinic is recruiting for a clinical trial that compares alcoholic liver disease, nonalcoholic steatohepatitis, and healthy con…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Diagnosis and Quantification of Hepatic Steatosis Using Near-infrared Spectroscopy [NA]
A clinical trial sponsored by Assistance Publique Hopitaux De Marseille is evaluating near-infrared spectroscopy to diagnose and quantify he…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study evaluating semaglutide alone and in combination with cilofexor and firsocostat for cirrhosis due to nonalcoholic steatohepatit…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects [Phase 2]
This clinical trial update notes the Phase 2 study of HM15211 (Efocipegtrutide) for nonalcoholic steatohepatitis is ongoing but currently no…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Digoxin In NASH (CODIN) [Phase 2]
Phase 2 trial (CODIN) evaluating digoxin for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension [Phase 2]
Boston Pharmaceuticals completed a Phase 2 study of BOS-580 in obese subjects at risk for or with biopsy-confirmed nonalcoholic steatohepati…
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis [Phase 2]
Phase 2 trial evaluating AZD2693 in carriers of the PNPLA3 148M risk allele with non-cirrhotic nonalcoholic steatohepatitis with fibrosis ha…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis [Phase 2]
A completed Phase 2 clinical trial evaluating saroglitazar magnesium for nonalcoholic steatohepatitis with fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH [Phase 2]
Phase 2 dose exploration trial of GSK4532990 in participants with non-alcoholic fatty liver disease, including NASH or suspected NASH, has c…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Study of ADI-PEG 20 Versus Placebo in Subjects With NASH [Phase 2]
Phase 2 clinical trial evaluating ADI-PEG 20 versus placebo in adults with nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS other · 2025-09-22Clinical Trial Update: To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects [Phase 1]
Phase 1 study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of BAR502 in healthy subjects; nonalcoholic steatoh…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [Phase 3]
Phase 3 study evaluating efruxifermin in adults with noninvasively diagnosed nonalcoholic steatohepatitis and nonalcoholic fatty liver disea…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Clinical trial assessing the prevalence of nonalcoholic fatty liver disease and advanced liver fibrosis in patients with Type 1 diabetes. Th…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis [Phase 2]
This clinical trial update reports results from a Phase 2 study evaluating the safety and efficacy of cotadutide given by subcutaneous injec…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: The Franciscus Obesity NASH Study
Clinical trial registry update for the Franciscus Obesity NASH Study, investigating NAFLD/NASH and obesity. The study status is ACTIVE_NOT_R…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Blood Collection Biorepository for Liver Disease Research
SUNY Buffalo is conducting a blood collection biorepository for liver disease research, currently recruiting participants to provide samples…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4 [Phase 1]
A Phase 1 study evaluating ontamalimab for nonalcoholic steatohepatitis with fibrosis (stages 1-4) has been terminated and results have been…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD） [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of multiple subcutaneous injections of B1344 in patients with nonalcoholic fatty liv…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Evaluation of Non-Invasive Tests for Metabolic Liver Disease
This clinical trial registry entry describes ongoing evaluation of non-invasive tests for metabolic liver disease, with recruitment currentl…